A three‐range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease

Abstract Introduction Alzheimer's disease consensus recommends biomarker dichotomization, a practice with well‐described clinical strengths and methodological limitations. Although neuroimaging studies have explored alternative biomarker interpretation strategies, a formally defined three‐range appr...

詳細記述

書誌詳細

主要な著者:	Wagner S. Brum, Marco Antônio deBastiani, Andrei Bieger, Joseph Therriault, João P. Ferrari‐Souza, Andréa L. Benedet, Paramita Saha‐Chaudhuri, Diogo O. Souza, Nicholas J. Ashton, Henrik Zetterberg, Tharick A. Pascoal, Thomas Karikari, Kaj Blennow, Pedro Rosa‐Neto, Eduardo R. Zimmer, Alzheimer's Disease Neuroimaging Initiative (ADNI)
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2022-01-01
シリーズ:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
主題:	Alzheimer's disease CSF biomarkers cut‐points prognostic modeling three‐range
オンライン･アクセス:	https://doi.org/10.1002/trc2.12270
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!